These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29044188)

  • 1. The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.
    Lim J; Park JH; Baude A; Yoo Y; Lee YK; Schmidt CR; Park JB; Fellenberg J; Zustin J; Haller F; Krücken I; Kang HG; Park YJ; Plass C; Lindroth AM
    Sci Rep; 2017 Oct; 7(1):13459. PubMed ID: 29044188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3.
    Lim J; Park JH; Baude A; Fellenberg J; Zustin J; Haller F; Krücken I; Kang HG; Park YJ; Plass C; Lindroth AM
    Sci Data; 2018 Dec; 5():180283. PubMed ID: 30532024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2.
    Lee E; Park YJ; Lindroth AM
    Cancer Gene Ther; 2024 Aug; 31(8):1177-1185. PubMed ID: 38811797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
    Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
    Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
    Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
    Lutsik P; Baude A; Mancarella D; Öz S; Kühn A; Toth R; Hey J; Toprak UH; Lim J; Nguyen VH; Jiang C; Mayakonda A; Hartmann M; Rosemann F; Breuer K; Vonficht D; Grünschläger F; Lee S; Schuhmacher MK; Kusevic D; Jauch A; Weichenhan D; Zustin J; Schlesner M; Haas S; Park JH; Park YJ; Oppermann U; Jeltsch A; Haller F; Fellenberg J; Lindroth AM; Plass C
    Nat Commun; 2020 Oct; 11(1):5414. PubMed ID: 33110075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
    [No Abstract]   [Full Text] [Related]  

  • 12. Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.
    Pasricha S; Pruthi M; Jajodia A; Kumar A; Gupta G; Sharma A; Tiwari A; Rohela H; Durga G; Kamboj M; Koyyala VPB; Mehta A
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):36-41. PubMed ID: 34347625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India.
    Rekhi B; Dave V; Butle A; Dharavath B; Khetale S; Redhu AK; Singh R; Dutt A
    Indian J Pathol Microbiol; 2024 Jul; 67(3):542-552. PubMed ID: 38391356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases.
    Yang L; Zhang H; Zhang X; Tang Y; Wu Z; Wang Y; Huang H; Fu X; Liu J; Hogendoorn PCW; Cheng H
    Ann Diagn Pathol; 2022 Apr; 57():151882. PubMed ID: 34995868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
    Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
    [No Abstract]   [Full Text] [Related]  

  • 19. H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone.
    Khazaei S; De Jay N; Deshmukh S; Hendrikse LD; Jawhar W; Chen CCL; Mikael LG; Faury D; Marchione DM; Lanoix J; Bonneil É; Ishii T; Jain SU; Rossokhata K; Sihota TS; Eveleigh R; Lisi V; Harutyunyan AS; Jung S; Karamchandani J; Dickson BC; Turcotte R; Wunder JS; Thibault P; Lewis PW; Garcia BA; Mack SC; Taylor MD; Garzia L; Kleinman CL; Jabado N
    Cancer Discov; 2020 Dec; 10(12):1968-1987. PubMed ID: 32967858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.